Xtant Medical Holdings, Inc.
XTNT
$0.54
-$0.01-1.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 133.93M | 133.08M | 127.77M | 122.30M | 117.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 133.93M | 133.08M | 127.77M | 122.30M | 117.27M |
| Cost of Revenue | 49.65M | 50.54M | 50.91M | 51.14M | 49.05M |
| Gross Profit | 84.27M | 82.54M | 76.86M | 71.16M | 68.22M |
| SG&A Expenses | 74.89M | 74.03M | 74.60M | 76.40M | 77.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 126.64M | 126.74M | 127.74M | 129.84M | 129.34M |
| Operating Income | 7.28M | 6.35M | 28.00K | -7.54M | -12.08M |
| Income Before Tax | 7.00M | 2.26M | -4.27M | -11.90M | -16.26M |
| Income Tax Expenses | 2.03M | 508.00K | 313.00K | 94.00K | 187.00K |
| Earnings from Continuing Operations | 4.97 | 1.75 | -4.58 | -11.99 | -16.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.97M | 1.75M | -4.58M | -11.99M | -16.45M |
| EBIT | 7.28M | 6.35M | 28.00K | -7.54M | -12.08M |
| EBITDA | 12.51M | 10.90M | 4.49M | -3.25M | -7.85M |
| EPS Basic | 0.04 | 0.02 | -0.03 | -0.09 | -0.12 |
| Normalized Basic EPS | 0.02 | 0.01 | -0.02 | -0.05 | -0.07 |
| EPS Diluted | 0.03 | 0.01 | -0.04 | -0.09 | -0.12 |
| Normalized Diluted EPS | 0.02 | 0.01 | -0.02 | -0.05 | -0.07 |
| Average Basic Shares Outstanding | 557.92M | 576.34M | 571.73M | 562.69M | 553.82M |
| Average Diluted Shares Outstanding | 592.75M | 600.54M | 585.26M | 566.96M | 553.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |